IRIS
LARUSSA, Tiziana
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.171
AS - Asia 968
EU - Europa 690
SA - Sud America 163
AF - Africa 16
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 6
Totale 3.025
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.111
SG - Singapore 398
CN - Cina 247
IT - Italia 226
DE - Germania 134
BR - Brasile 128
IN - India 119
GB - Regno Unito 102
VN - Vietnam 77
FI - Finlandia 69
SE - Svezia 56
CA - Canada 44
IR - Iran 38
NL - Olanda 24
TR - Turchia 18
AR - Argentina 15
RU - Federazione Russa 14
TW - Taiwan 11
AU - Australia 10
MX - Messico 10
PL - Polonia 10
BD - Bangladesh 8
FR - Francia 8
UA - Ucraina 8
HK - Hong Kong 7
ID - Indonesia 7
IQ - Iraq 7
EC - Ecuador 6
RO - Romania 6
UZ - Uzbekistan 6
ES - Italia 5
IL - Israele 5
PY - Paraguay 5
CL - Cile 4
EU - Europa 4
ZA - Sudafrica 4
AT - Austria 3
CZ - Repubblica Ceca 3
JP - Giappone 3
LT - Lituania 3
MA - Marocco 3
PH - Filippine 3
PK - Pakistan 3
SA - Arabia Saudita 3
SK - Slovacchia (Repubblica Slovacca) 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AE - Emirati Arabi Uniti 2
AL - Albania 2
AO - Angola 2
BE - Belgio 2
CH - Svizzera 2
CU - Cuba 2
EG - Egitto 2
HU - Ungheria 2
PS - Palestinian Territory 2
RS - Serbia 2
UY - Uruguay 2
BB - Barbados 1
BG - Bulgaria 1
CI - Costa d'Avorio 1
CO - Colombia 1
DK - Danimarca 1
DZ - Algeria 1
EE - Estonia 1
ET - Etiopia 1
GF - Guiana Francese 1
GR - Grecia 1
HN - Honduras 1
JM - Giamaica 1
KE - Kenya 1
KW - Kuwait 1
LB - Libano 1
LK - Sri Lanka 1
MD - Moldavia 1
MG - Madagascar 1
NI - Nicaragua 1
NO - Norvegia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
VE - Venezuela 1
Totale 3.025
Salva come PNG Salva come JPEG
Città #
Chandler 152
Singapore 127
Munich 114
Dallas 106
Chicago 90
London 86
Santa Clara 82
Hefei 79
Bengaluru 77
Lawrence 68
Princeton 68
Milan 66
Ashburn 64
Helsinki 47
Beijing 44
Wilmington 41
Ho Chi Minh City 30
Ottawa 30
Catanzaro 28
Des Moines 21
Redwood City 19
São Paulo 19
Hanoi 17
Mumbai 17
Turku 14
Los Angeles 12
Mendicino 12
Shanghai 11
Guangzhou 10
Istanbul 9
Praia A Mare 9
Boardman 8
Phoenix 8
Rome 8
Collegeville 7
New York 7
Pune 7
Tehran 7
The Dalles 7
Cittanova 6
Redmond 6
Warsaw 6
Brooklyn 5
Chennai 5
Curitiba 5
Da Nang 5
Hanover 5
Hong Kong 5
Jyväskylä 5
Montreal 5
Norwalk 5
Rio de Janeiro 5
San Francisco 5
Shenzhen 5
Boston 4
Clearwater 4
Horia 4
Selargius 4
Taipei 4
Bade District 3
Bari 3
Belo Horizonte 3
Benevento 3
Brasília 3
Bratislava 3
Campinas 3
Charlotte 3
Council Bluffs 3
Dhaka 3
Jiaxing 3
Kahramanmaraş 3
Karachi 3
Miguel Hidalgo 3
Nanjing 3
Naples 3
Paris 3
Quito 3
Rende 3
Riyadh 3
San Juan 3
Stockholm 3
São Bernardo do Campo 3
Tashkent 3
Tel Aviv 3
Wuxi 3
Zabki 3
Ankara 2
Ann Arbor 2
Atlanta 2
Baghdad 2
Biên Hòa 2
Buffalo 2
Bungarribee 2
Calumpit 2
Cape Town 2
Capurso 2
Casablanca 2
Castel Campagnano 2
Chelsea 2
Chittagong 2
Totale 1.835
Salva come PNG Salva come JPEG
Nome #
Adverse drug reactions during biologic therapy in inflammatory disease: real life data from the pharmacovigilance project in the Calabria region 235
Dietary polyphenolsand non-alcoholic fatty liver disease 96
A Framework for Patient Data Management and Analysis in Randomised Clinical Trials 78
Efficacy of Mediterranean diet and antioxidants in overweight patients with non-alcoholic fatty liver disease. 68
Barriers And Facilitators In Conducting Clinical Trials In Inflammatory Bowel Disease: A Monocentric Italian Survey. 67
COVID-19 and Inflammatory Bowel Disease: Patient Knowledge and Perceptions in a Single Center Survey 66
The role of gluten-free diet in nonalcoholic fatty liver disease development 66
Anxiety and Gastrointestinal Symptoms Related to COVID-19 during Italian Lockdown 65
Safety profiles of biologic agents for inflammatory bowel diseases: a prospective pharmacovigilance study in Southern Italy 60
Safety profile of intravenous iron in inflammatory bowel disease: an up-to-date overview 59
Long-term, Real-life, Observational Study in Treating Outpatient Ulcerative Colitis with Golimumab 57
Real-life burden of adverse reactions to biological therapy in inflammatory bowel disease: a single-centre prospective case series. 55
SARS-CoV-2 Spread Dynamics in Italy: The Calabria Experience 53
Oleuropein Decreases Cyclooxygenase-2 and Interleukin-17 Expression and Attenuates Inflammatory Damage in Colonic Samples from Ulcerative Colitis Patients 52
Effect of selective cyclooxygenase (Cox)-2 Inhibition and proton pump inhibitors (PPI) therapy on TH1 immune response in human gastric mucosa 51
Gut Microbiota and Liver Interaction through Immune System Cross-Talk: A Comprehensive Review at the Time of the SARS-CoV-2 Pandemic. 50
Effectiveness and safety of adalimumab to treat outpatient ulcerative colitis: A real-life multicenter, observational study in primary inflammatory bowel disease centers 49
Decreased circulating interleukin-33 concentration in Helicobacter pylori-infected patients with peptic ulcer: Evaluation of its association with a cytokine gene polymorphism, gender of patients and bacterial virulence factor CagA 47
Gut microbiota and non-alcoholic fatty liver disease 47
Enhanced expression of indole amine 2,3-dioxygenase (IDO) in Helicobacter pylori-infected human gastric muciosa downregulates interleukin (IL)-17 and upregulates IL-4 production. 45
Helicobacter pylori and T Helper Cells: Mechanisms of Immune Escape and Tolerance 44
Effectiveness and Safety of Golimumab in Treating Outpatient Ulcerative Colitis: A Real-Life Prospective, Multicentre, Observational Study in Primary Inflammatory Bowel Diseases Centers 44
Enhanced expression of indoleamine 2,3-dioxygenase (IDO) in Helicobacter pylori-infected human gastric mucosa modulates TH1/TH2 patway and interleukin (IL)-17 production. 44
Bone mineralization in celiac disease 44
Comparison of Performances of Adalimumab Biosimilars SB5, ABP501, GP2017, and MSB11022 in Treating Patients with Inflammatory Bowel Diseases: A Real-Life, Multicenter, Observational Study 43
Comparison of performances of infliximab biosimilars CT-P13 versus SB2 in the treatment of inflammatory bowel diseases: a real-life multicenter, observational study in Italy 43
Lactobacillus paracasei F19 versus placebo for the prevention of proton pump inhibitor-induced bowel symptoms: a randomized clinical trial 42
Multifaceted pathogenesis of liver steatosis in inflammatory bowel disease: A systematic review 41
Infliximab biosimilar CT-P13 is effective and safe in treating inflammatory bowel diseases: a real-life multicenter, observational study in Italian primary inflammatory bowel disease centers 40
Diminished circulating concentration of interleukin-35 in Helicobacter pylori-infected patients with peptic ulcer: Its association with FOXP3 gene polymorphism, bacterial virulence factor CagA, and gender of patients 40
Oleuropein decreases interleukin-17 and attenuates inflammatory damage in colonic mucosa from ulcerative colitis patients 38
Effect of selective cyclooxygenase (COX)-2 inhibition and proton pump inhibitors (PPI) therapy on TH1 immune response in human gastric mucosa 38
Real-life efficacy and safety of Ustekinumab as second- or third-line therapy in Crohn's disease: results from a large Italian cohort study 38
Downregulation of Interleukin- (IL-) 17 through Enhanced Indoleamine 2,3-Dioxygenase (IDO) Induction by Curcumin: A Potential Mechanism of Tolerance towards Helicobacter pylori 37
Self-Prescribed Dietary Restrictions are Common in Inflammatory Bowel Disease Patients and Are Associated with Low Bone Mineralization 36
Reduced bone mineral density is frequent in treated adult coeliac disease not with standing complete normalization of duodenal lesions. 36
Vedolizumab is effective and safe in real-life treatment of inflammatory bowel diseases outpatients: A multicenter, observational study in primary inflammatory bowel disease centers 35
Enhanced activation of cyclooxygenase-2 down-regulates Th1 signaling pathway in Helicobacter pylori-infected human gastric mucosa 35
Crohn disease: Identification, diagnosis, and clinical management. 35
Long-term real-life efficacy and safety of infliximab and adalimumab in the treatment of inflammatory bowel diseases outpatients 34
Very low vitamin D level is an independent risk factor for bone demineralization in IBD patients 34
Normal Bone Mineral Density Associates with Duodenal Mucosa Healing in Adult Patients with Celiac Disease on a Gluten-Free Diet 32
Potential role of fecal gluten immunogenic peptides to assess dietary compliance in celiac patients 32
Survey on alcohol consumption in a gastroenetrology outpatient center in southern Italy. 32
Mediterranean diet and probiotics supplementation to treat non-alcoholic fatty liver disease 32
Treatment of relapsing mild-to-moderate ulcerative colitis with the probiotic VSL#3 as adjunctive to standard pharmeceutical treatment: a double-blind, randomized, placebo-controlled study 31
Living with inflammatory bowel diseases: patients’ perceptions and unmet needs from a single-center Italian survey 30
SURVEY ON ALCOHOL CONSUMPTION IN A GASTROENTEROLOGY OUTPATIENT CENTER IN SOUTHERN ITALY 30
Potential role of nutraceutical compounds in inflammatory bowel disease 30
The protective effects of resveratrol on ulcerative colitis via changing the profile of Nrf2 and IL-1β protein 30
Liver Cirrhosis Complications Management At The Emergency Department 30
Gut microbiota in inflammatory bowel disease: a target for therapy not to be missed. 30
Replacement of Adalimumab Originator to Adalimumab Biosimilar for a Non-Medical Reason in Patients with Inflammatory Bowel Disease: A Real-life Comparison of Adalimumab Biosimilars Currently Available in Italy 29
High prevalence of polymorphism and low activity of thiopurine methiltransferase in patients with inflammatory bowel disease. 29
Epidemiology of Helicobacter pylori infection: the Sorbo San Basile study. 29
High Exposure, Spontaneous Clearance, and Low Incidence of Active Helicobacter pylori Infection: The Sorbo San Basile Study 29
Trends and characteristics associated with dietary triggers and psychological distress in patients with irritable bowel syndrome: a cross-sectional study 28
Enhanced expression of indoleamine 2,3-dioxygenase in Helicobacter pylori-infected human gastric mucosa modulates Th1/Th2 pathway and interleukin 17 production 28
Enhanced Expression of Indoleamine 2,3-Dioxygenase (IDO) in Helicobacter pylori-Infected Human Gastric Mucosa Modulates TH1/Th2 Pathway and Interleukin (IL)-17 Production. 28
T cell subsets play an important role in the determination of the clinical outcome of Helicobacter pylori infection 28
Increased Indoleamine 2, 3-Dioxygenase expression modulates Th1/Th17/Th22 and Treg pathway in humans with Helicobacter Pylori-Infected gastric mucosa 28
Short-term Therapy with Celecoxib and Lansoprazole Modulates Th1/Th2 Immune Response in Human Gastric Mucosa 27
Use of Complementary and Alternative Medicine by Patients with Irritable Bowel Syndrome According to the Roma IV Criteria: A Single-Center Italian Survey 25
Toll-like receptor 2: An important immunomodulatory molecule during Helicobacter pylori infection 25
No evidence of circulating autoantibodies against osteoprotegerin in treated celiac patients with low bone mineral density. 24
Vitamin D down-regulates the expression of some Th17 cell-related cytokines, key inflammatory chemokines, and chemokine receptors in experimental autoimmune encephalomyelitis 24
The Reality of Patient-Reported Outcomes of Health-Related Quality of Life in an Italian Cohort of Patients with Inflammatory Bowel Disease: Results from a Cross-Sectional Study 24
Liver steatosis in celiac disease: the open door 23
Nutrigenomics and Nutrigenetics in Metabolic- (Dysfunction) Associated Fatty Liver Disease: Novel Insights and Future Perspectives 23
Enhanced expression of indoleamine 2,3-dioxygenase in Helicobacter pylori-infected human gastric mucosa modulates Th1/Th2 pathway and interleukin 17 production 22
No evidence of circulating autoantibodies against osteoprotegerin in patients with celiac disease 22
From Pre- and Probiotics to Post-Biotics: A Narrative Review. 22
OLEUROPEIN EXERTS ANTIOXIDANT ACTIVITY AND REDUCES THE EXPRESSION OF COX-2 AND PROINFLAMMATORY CYTOKINES IN CACO-2 CELLS AND COLONIC MUCOSA FROM ULCERATIVE COLITIS PATIENTS 21
Beneficial effects of coffee in non-alcoholic fatty liver disease: a narrative review 21
High prevalence of polymorphism and low activity of thiopurine methyltransferase in patients with inflammatory bowel disease. 19
Refractory ulcerative colitis complicated by cytomegalovirus infection successfully treated with valganciclovir 19
Olive Tree Biophenols in Inflammatory Bowel Disease: When Bitter is Better 16
Totale 3.139
Salva come PNG Salva come JPEG
Categoria #
all - tutte 34.069
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.069
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202183 0 0 0 0 0 13 10 19 32 7 2 0
2021/2022258 8 7 14 49 17 4 10 48 22 26 37 16
2022/2023610 138 35 48 41 34 36 7 50 55 96 62 8
2023/2024290 69 20 25 16 10 75 6 15 27 2 9 16
2024/2025884 119 45 43 18 70 121 64 42 159 8 73 122
2025/2026845 84 185 142 211 188 35 0 0 0 0 0 0
Totale 3.139